BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Closing Bell: Economic Confusion Rules (AMRN, USO, GLD, VRX, HAUP, MON, TGT)]]>http://www.bloggingstocks.com/2011/01/06/closing-bell-economic-confusion-rules-amrn-uso-gld-vrx-hau/http://www.bloggingstocks.com/2011/01/06/closing-bell-economic-confusion-rules-amrn-uso-gld-vrx-hau/http://www.bloggingstocks.com/2011/01/06/closing-bell-economic-confusion-rules-amrn-uso-gld-vrx-hau/#commentsFiled under: , , ,

Thursday was marked by mixed markets with technology stocks higher and the rest of the market mixed to lower. The dollar was up and both oil and gold were down. A lackluster jobless claims might have taken away some of the zing that the ADP and TrimTabs data showed for employment trends ahead of Friday's non-Farm Payrolls and unemployment rate due Friday morning. Still, many key names were on the move today.

Here are the unofficial closing bell levels:

Dow Jones 11,697.31 -25.58 (-0.22%)
S&P 500 1,273.85 -2.71 (-0.21%)
Nasdaq 2,709.89 +7.69 (0.28%)

Continue reading Closing Bell: Economic Confusion Rules (AMRN, USO, GLD, VRX, HAUP, MON, TGT)

Closing Bell: Economic Confusion Rules (AMRN, USO, GLD, VRX, HAUP, MON, TGT) originally appeared on BloggingStocks on Thu, 06 Jan 2011 16:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AMRNGLDHAUPMONTGTVRXThu, 06 Jan 2011 16:30:00 EST<![CDATA[Analyst Calls: ACLI, ADM, ANF, BLK, BP, COST, EMC, FO, NE, PEET, UNFI ...]]>http://www.bloggingstocks.com/2010/10/11/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/10/11/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/10/11/analyst-upgrades-downgrades/#commentsFiled under: , , , , , , ,

Analyst Upgrades

  • Deutsche Bank upgraded EMC (EMC) to buy from hold after channel checks indicated storage demand remains solid. The firm sees potential upside in 2011 from the company's new products and upped its target for shares to $25 from $20.
  • BB&T upgraded American Commercial (ACLI) to buy with a $50 target based on pricing leverage and cost reductions.
  • Argus upgraded Abercrombie (ANF) to buy with a $52 target based on accelerating comps.
  • PerkinElmer (PKI) was upgraded to equal weight from underweight at Barclays.
  • Valeant (VRX) was upgraded to market perform from underperform at Wells Fargo with a $26 to $28 valuation range.
  • Blackrock (BLK) was upgraded to buy from hold at Deutsche Bank.

Continue reading Analyst Calls: ACLI, ADM, ANF, BLK, BP, COST, EMC, FO, NE, PEET, UNFI ...

Analyst Calls: ACLI, ADM, ANF, BLK, BP, COST, EMC, FO, NE, PEET, UNFI ... originally appeared on BloggingStocks on Mon, 11 Oct 2010 11:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AbercrombieACLIADManalyst upgradesANFBlackrockBLKBPCEVACOSTCostcodowngradesEMCFOFortune BrandsHealthSouthHLSHSinitiationsinthenewsMTWNEPEETPerkinElmerPKIUNFIVLCCFVRXMon, 11 Oct 2010 11:00:00 EST<![CDATA[Analyst Calls: AAPL, ALL, AOL, AVP, AZPN, BMY, COO, F, K, MSFT, PENN, UAL ...]]>http://www.bloggingstocks.com/2010/10/04/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/10/04/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/10/04/analyst-upgrades-downgrades/#commentsFiled under: , , , , , , , , , ,

Analyst Upgrades

  • Merriman upgraded Penn National (PENN) to buy from neutral, citing the company's strong balance sheet and management team. The firm also raised its target range for shares to $34 to $37.60.
  • BMO Capital upgraded Cooper Companies (COO) to outperform from market perform and raised its price target to $55 from $46. The firm sees upside to Street estimates and increased visibility.
  • Argus upgraded Watson Pharma (WPI) to buy from hold based on valuation.
  • Phillips-Van Heusen (PVH) was upgraded to conviction buy from neutral at Goldman.
  • Allstate (ALL) was upgraded to overweight from neutral at JPMorgan.
  • Weingarten Realty (WRI) was upgraded to neutral from underperform at BofA/Merrill.

Continue reading Analyst Calls: AAPL, ALL, AOL, AVP, AZPN, BMY, COO, F, K, MSFT, PENN, UAL ...

Analyst Calls: AAPL, ALL, AOL, AVP, AZPN, BMY, COO, F, K, MSFT, PENN, UAL ... originally appeared on BloggingStocks on Mon, 04 Oct 2010 12:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AAPLALLAllstateanalyst upgradesAOLAppleAvonAVPAZPNBMYBristol-MyersCFRCOOCooperCullenFrostdowngradesDREFFordinitiationsinthenewsKKelloggMicrosoftMSFTPENNPenn NationalPhillips-Van HeusenPVHUALUnited ContinentalValeantVOLCVRXWPIWRIMon, 04 Oct 2010 12:00:00 EST<![CDATA[Three Small Cap Buyout Targets]]>http://www.bloggingstocks.com/2010/09/07/three-small-cap-buyout-targets/http://www.bloggingstocks.com/2010/09/07/three-small-cap-buyout-targets/http://www.bloggingstocks.com/2010/09/07/three-small-cap-buyout-targets/#commentsFiled under:

A 21-month run of rock-bottom interest rates have created a perfect environment for corporate bonds --- and as bond yields fall, bond prices rise and investors and companies have made out like bandits. This has put so much cash in corporate coffers that cash (as a percentage of S&P 500 market capitalization and excluding financials) has soared from just 3% of market value back in 1999 to more than 12.5% today! This cash is burning a hole in the pockets of many companies, and they are starting to use it to make bids for other companies so they can grab market share and expand on the cheap.

That's great news for small cap stocks with strong fundamentals, since these are always prime buyout targets. And here are three:

Continue reading Three Small Cap Buyout Targets

Three Small Cap Buyout Targets originally appeared on BloggingStocks on Tue, 07 Sep 2010 15:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>acme packetapktcscofeaturedjnprrdcmsmall cap stocksValeantPharmaceuticalsvrxTue, 07 Sep 2010 15:00:00 EST<![CDATA[GlaxoSmithKline Gets Good News from FDA Regarding Epilepsy Drug]]>http://www.bloggingstocks.com/2010/08/12/glaxosmithkline-gets-good-news-from-fda-regarding-epilepsy-drug/http://www.bloggingstocks.com/2010/08/12/glaxosmithkline-gets-good-news-from-fda-regarding-epilepsy-drug/http://www.bloggingstocks.com/2010/08/12/glaxosmithkline-gets-good-news-from-fda-regarding-epilepsy-drug/#commentsFiled under: , ,

GlaxoSmithKline (GSK) logoGlaxoSmithKline (GSK - option chain) shares are rising today after the company said an FDA advisory panel unanimously backed its epilepsy drug, ezogabine. GSK codeveloped the drug with Valeant Pharmaceuticals (VRX). If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on AMGN.

GSK opened this morning at $37.17. So far today the stock has hit a low of $37.00 and a high of $37.39. As of 12:15, GSK is trading at $37.22 up 0.76 (2.1%). The chart for GSK looks neutral and S&P gives GSK a neutral 3 STARS (out of 5) hold ranking.

Continue reading GlaxoSmithKline Gets Good News from FDA Regarding Epilepsy Drug

GlaxoSmithKline Gets Good News from FDA Regarding Epilepsy Drug originally appeared on BloggingStocks on Thu, 12 Aug 2010 13:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>epilepsyFDAGlaxoSmithKlineGSKinthenewsInvestors ObserverValeant PharmaceuticalsVRXThu, 12 Aug 2010 13:40:00 EST<![CDATA[Affymax, Jefferies and Others Heating Up in Google Searches]]>http://www.bloggingstocks.com/2010/06/22/affymax-jefferies-cypress-bioscience-in-google-searches/http://www.bloggingstocks.com/2010/06/22/affymax-jefferies-cypress-bioscience-in-google-searches/http://www.bloggingstocks.com/2010/06/22/affymax-jefferies-cypress-bioscience-in-google-searches/#commentsIt appears that the Chinese yuan, drug makers and investment banks caught the attention of traders Tuesday -- at least, that's what they're searching for.

If you want to know what stocks traders are interested in right now at this very second, you need look no further than what's hot in Google.

Here's what's hot today.

Continue reading Affymax, Jefferies and Others Heating Up in Google Searches

Affymax, Jefferies and Others Heating Up in Google Searches originally appeared on BloggingStocks on Tue, 22 Jun 2010 12:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>affyaffymaxBiovailBVFchinese yuancybCYPBCypress Biosciencesgoogleinthenewsjefjefferies groupValeantvrxWisdomTree DreyfusTue, 22 Jun 2010 12:40:00 EST<![CDATA[Analyst Calls: AFFY, AIPC, BIG, BVF, ECLP, EXPR, FTI, LNCR, RRTS, VRX ...]]>http://www.bloggingstocks.com/2010/06/22/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/06/22/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/06/22/analyst-upgrades-downgrades/#commentsFiled under: , ,

Analyst Upgrades

  • Citigroup upgraded FMC Technologies (FTI) to buy from hold, citing pent-up deepwater drilling demand and valuation. Despite upgrading, the firm lowered its target for shares to $69 from $77.
  • Piper Jaffray upgraded Valeant (VRX) to overweight from neutral following the company's merger with Biovail (BVF) and raised its target for shares to $53 from $43.
  • Deutsche Bank upgraded Lincare Holdings (LNCR) to buy from hold, citing valuation and the company's dividend initiation. The firm upped its target for shares to $37 from $35.
  • Ariba (ARBA) was upgraded to overweight from neutral at JPMorgan.
  • Crucell (CRXL) was upgraded to buy from hold at RBS.
  • ENI SpA (E) was upgraded to buy from neutral at Goldman.

Continue reading Analyst Calls: AFFY, AIPC, BIG, BVF, ECLP, EXPR, FTI, LNCR, RRTS, VRX ...

Analyst Calls: AFFY, AIPC, BIG, BVF, ECLP, EXPR, FTI, LNCR, RRTS, VRX ... originally appeared on BloggingStocks on Tue, 22 Jun 2010 11:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AFFYAIPCanalyst upgradesARBAAYRBIGBVFCRXLDNRdowngradesEECLPETREXPRFTIGSICinitiationsLNCRMDRXRRTSSDVRXTue, 22 Jun 2010 11:20:00 EST<![CDATA[Valeant Pharma (VRX) falls on bearish Barron's coverage]]>http://www.bloggingstocks.com/2009/11/23/valeant-pharma-vrx-falls-on-bearish-barrons-coverage/http://www.bloggingstocks.com/2009/11/23/valeant-pharma-vrx-falls-on-bearish-barrons-coverage/http://www.bloggingstocks.com/2009/11/23/valeant-pharma-vrx-falls-on-bearish-barrons-coverage/#commentsFiled under: , , , , ,

VRX logoValeant Pharmaceuticals (VRX - option chain) stock is trading lower today after an article in Barron's (subscription required) over the weekend said the company could see trouble ahead if its experimental epilepsy drug, which is undergoing the regulatory review process, is not profitable enough to offset declining royalties from its hepatitis C treatment. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on VRX.

This morning, VRX opened at $32.15. So far today the stock has hit a high of $32.95 and a low of $31.88. As of 11:30, VRX is trading at $32.07, down $1.21 (-3.6%). The chart for VRX looks bullish.

Continue reading Valeant Pharma (VRX) falls on bearish Barron's coverage

Valeant Pharma (VRX) falls on bearish Barron's coverage originally appeared on BloggingStocks on Mon, 23 Nov 2009 13:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Barronsinthenewsinvestors observerInvestorsObserveroptionsValeant PharmaceuticalsValeantPharmaceuticalsVRXMon, 23 Nov 2009 13:20:00 EST<![CDATA[Save money, give stock to charity!]]>http://www.bloggingstocks.com/2009/06/16/save-money-give-stock-to-charity/http://www.bloggingstocks.com/2009/06/16/save-money-give-stock-to-charity/http://www.bloggingstocks.com/2009/06/16/save-money-give-stock-to-charity/#commentsFiled under: , ,

Surviving this recession is foremost on peoples' minds, but giving to charity is especially important in times like these. So how can you effectively give while preserving your net worth?

If you plan on liquidating any profitable, or taxable, positions in the stock market thanks to the current uptrend and also want to give to your favorite charity, the strategy outlined below is key to optimizing your gift, as well as your capital.

Though giving cash to causes is the most popular form of charity, desperate times call for creative measures, and any type of gift will be gladly accepted. By giving stock directly to charity, and bear in mind that the stock must be in your portfolio for one year or more as short-term capital gains are not applicable, you not only avoid capital gains taxes on your gains, but you can actually use the gift of your stock as a tax deduction. Hence, the cost of your gift is lower than giving cash directly. Think of it as an overall investment for yourself and the charity.

Continue reading Save money, give stock to charity!

Save money, give stock to charity! originally appeared on BloggingStocks on Tue, 16 Jun 2009 14:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>algtbdsicharity donationsCharityDonationscpsiddupfeaturedicuimygnpalmpnrargldrosttevavrxTue, 16 Jun 2009 14:00:00 EST<![CDATA[Analyst upgrades, downgrades and initiations: CI, CCE, JBLU, LIZ, LLL]]>http://www.bloggingstocks.com/2009/05/14/analyst-upgrades-downgrades-and-initiations-ci-cce-jblu-liz/http://www.bloggingstocks.com/2009/05/14/analyst-upgrades-downgrades-and-initiations-ci-cce-jblu-liz/http://www.bloggingstocks.com/2009/05/14/analyst-upgrades-downgrades-and-initiations-ci-cce-jblu-liz/#commentsFiled under: , , , , , , ,

Analyst upgrades:

  • Oppenheimer upgraded FTI Consulting (NYSE:FCN) to Outperform from Perform on expectations the stock will outperform in the second half of 2009 due to easier comparisons and a "deeper and longer" restructuring cycle. The firm has a $62 target on shares.
  • Citigroup upgraded Cigna (NYSE:CI) to Hold from Sell to reflect reduced balance sheet risk following the company's capital raise and the potential for a PBM sale. The firm raised its target price to $23 from $13.
  • Goldman expects Coca-Cola Enterprises (NYSE:CCE) to benefit from favorable soda demand and lower commodity costs. The firm upgraded shares to Conviction Buy from Buy and has a $20 target on the stock.
  • Novellus (NASDAQ:NVLS) was raised to Buy from Neutral at Bank of America/Merrill.
  • CME Group (NASDAQ:CME) was upgraded at JP Morgan to Neutral from Underweight.
  • Allegiant (NASDAQ:ALGT) was upgraded to Overweight from Equal Weight at Morgan Stanley.

Continue reading Analyst upgrades, downgrades and initiations: CI, CCE, JBLU, LIZ, LLL

Analyst upgrades, downgrades and initiations: CI, CCE, JBLU, LIZ, LLL originally appeared on BloggingStocks on Thu, 14 May 2009 12:45:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>algtaluapdaznccecicmeeqixfcnjblulizllllpxncinvlspdcpxvrxThu, 14 May 2009 12:45:00 EST